EMFAT
Emerald Mutual Fund Advisers Trust’s Haemonetics HAE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,280
| Closed | -$2.84M | – | 232 |
|
|
2024
Q2 | $2.84M | Hold |
34,280
| – | – | 0.15% | 116 |
|
|
2024
Q1 | $2.93M | Sell |
34,280
-75,031
| -69% | -$6.4M | 0.15% | 117 |
|
|
2023
Q4 | $9.35M | Sell |
109,311
-325
| -0.3% | -$27.8K | 0.49% | 81 |
|
|
2023
Q3 | $9.82M | Sell |
109,636
-32,866
| -23% | -$2.94M | 0.59% | 77 |
|
|
2023
Q2 | $12.1M | Hold |
142,502
| – | – | 0.66% | 70 |
|
|
2023
Q1 | $11.8M | Buy |
142,502
+2,880
| +2% | +$238K | 0.7% | 66 |
|
|
2022
Q4 | $11M | Sell |
139,622
-126,841
| -48% | -$9.98M | 0.68% | 63 |
|
|
2022
Q3 | $19.7M | Sell |
266,463
-15,430
| -5% | -$1.14M | 1.25% | 23 |
|
|
2022
Q2 | $18.4M | Buy |
281,893
+60,125
| +27% | +$3.92M | 1.06% | 29 |
|
|
2022
Q1 | $14M | Buy |
+221,768
| New | +$14M | 0.62% | 63 |
|
|
2020
Q3 | – | Sell |
-70,013
| Closed | -$6.27M | – | 335 |
|
|
2020
Q2 | $6.27M | Sell |
70,013
-165,727
| -70% | -$14.8M | 0.3% | 104 |
|
|
2020
Q1 | $23.5M | Sell |
235,740
-3,500
| -1% | -$349K | 1.47% | 15 |
|
|
2019
Q4 | $27.5M | Buy |
239,240
+60,263
| +34% | +$6.92M | 1.12% | 21 |
|
|
2019
Q3 | $22.6M | Buy |
178,977
+12,360
| +7% | +$1.56M | 1% | 29 |
|
|
2019
Q2 | $20.1M | Buy |
166,617
+21,690
| +15% | +$2.61M | 0.8% | 39 |
|
|
2019
Q1 | $12.7M | Buy |
144,927
+24,500
| +20% | +$2.14M | 0.51% | 67 |
|
|
2018
Q4 | $12M | Buy |
+120,427
| New | +$12M | 0.56% | 62 |
|